Pharmafile Logo

VBH

- PMLiVE

FDA approves Novartis’ Pluvicto for prostate cancer

The treatment is the first FDA approved targeted radioligand therapy for mCRPC patients

- PMLiVE

Charting patient pathways with precision for better healthcare

Making a healthcare system tick is like creating a Swiss watch – it requires patience, persistence and a sharp eye for detail

- PMLiVE

Novartis and Voyager Therapeutics agree on gene therapy deal worth 1.7bn

The licence option agreement is for next-generation gene therapy vectors for neurological diseases

- PMLiVE

International Women’s Day 2022

This year the theme of International Women’s Day is ‘break the bias’, focussing on how our actions in our communities, workplaces, schools and universities can unite our individual actions with...

Mednet Group

Onyx Health Announces a “Double Hatrick” of New Appointments

Onyx Health continues to expand with six new appointments to its creative and communication teams, due to increased growth in its international client portfolio work.

Onyx Health

- PMLiVE

Onyx Health Tackles Type 2 Diabetes with Diabetes Lifestyle Doctors

Onyx Health has teamed up with Diabetes Lifestyle Doctors to tackle the diabetes care gap in the NHS and help patients suffering from type 2 diabetes across the UK. (Pictured...

Onyx Health

- PMLiVE

Improving outcomes in oncology: patient centricity and mental health

A key challenge in healthcare is how to proactively address unmet needs using patient-centric campaigns and resources, particularly in a time when ‘in-person’ care is limited. How can this be...

Mednet Group

VR/AR Applications for Training and Healthcare

Mike Waldron, CEO and Co-Founder of Propel VR, discusses how virtual reality (VR) and augmented reality (AR) can be leveraged in the healthcare industry, including specific applications of VR/AR for...

Impetus Digital

- PMLiVE

The doctor will text you now: Why healthcare providers cannot underestimate the importance of communicating change

Healthcare communication needs to switch from ‘transmit’ to ‘receive’, listening to what patients need and embracing the plethora of communication tools wholeheartedly.

Say Communications

Transforming Healthcare Through the Power of Patients

Esther Schorr, Co-founder and Chief Operating Officer of Patient Power LLC, discusses non-linear journey to patient education and Patient Power's mission to empower patients and their loved ones to take...

Impetus Digital

- PMLiVE

Novartis to pay up to $1.5bn for Gyroscope

The acquisition of ocular gene therapy company, Gyroscope, adds GT005 to the Novartis portfolio – a one-time gene therapy for geographic atrophy, a leading cause of blindness

- PMLiVE

Novartis strengthens links with BeiGene in a deal that could be worth up to $1bn

Novartis is to pay $300m upfront to BeiGene in a multifaceted deal to enhance its oncology portfolio and expand coverage of the Chinese market

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links